Cytosponge Protocol IRB 11-006429

NATerminatedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

June 7, 2016

Study Completion Date

June 7, 2016

Conditions
Eosinophilic Esophagitis
Interventions
DEVICE

Cytosponge

An ingestible gelatin capsule containing a compressed mesh attached to a string. The capsule is swallowed and once in the stomach, the gelatin dissolves and a spherical mesh of 3 cm diameter is released. The mesh is withdrawn through the mouth by the attached string and a cytologic specimen is collected.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University of Cambridge

OTHER

lead

Mayo Clinic

OTHER